openPR Logo
Press release

Revolutionizing Healthcare: Explore the Booming Global Biomarkers Market and Its Impact on Modern Medicine

12-12-2024 10:10 AM CET | Health & Medicine

Press release from: Mordor Intelligence

Biomarkers Market Size

Biomarkers Market Size

Mordor Intelligence has published a new report on the biomarkers market, offering a comprehensive analysis of trends, growth drivers, and future projections.

The global biomarkers market is poised for significant growth, with projections indicating an increase from USD 56.72 billion in 2024 to USD 87.64 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.09%. This expansion is primarily attributed to the escalating prevalence of chronic diseases, heightened demand for early diagnostic tools, and substantial investments in biomarker research and development.

Report Overview: https://www.mordorintelligence.com/industry-reports/biomarkers-market

Key Trends

Increasing Prevalence of Chronic Diseases

The surge in chronic conditions such as cancer, cardiovascular disorders, and diabetes has intensified the need for precise diagnostic and prognostic biomarkers. These biomarkers are instrumental in early disease detection, monitoring disease progression, and evaluating therapeutic responses, thereby enhancing patient outcomes.

Advancements in Diagnostic Technologies

Innovations in diagnostic methodologies, including next-generation sequencing (NGS), mass spectrometry, and bioinformatics, have facilitated the discovery and validation of novel biomarkers. These technological strides have expanded the application of biomarkers in personalized medicine, enabling tailored therapeutic strategies based on individual patient profiles.

Growing Emphasis on Non-Invasive Testing

There is a discernible shift towards non-invasive biomarker testing, particularly for conditions like cancer and cardiovascular diseases. Non-invasive tests, such as liquid biopsies, offer a safer and more convenient alternative to traditional invasive procedures, thereby improving patient compliance and facilitating early disease detection.

Collaborative Research and Development Efforts

The biomarker industry is witnessing increased collaboration between pharmaceutical companies, research institutions, and diagnostic laboratories. These partnerships aim to accelerate the discovery, validation, and commercialization of biomarkers, thereby enhancing their clinical utility and expanding their market presence.

Market Segmentation

The biomarkers market is segmented based on disease, type, mechanism, end user, and geography:

By Disease:

Cancer: Utilization of biomarkers for early detection, prognosis, and monitoring of various cancers.

Cardiovascular Disorders: Application of biomarkers in diagnosing and managing heart-related conditions.

Neurological Disorders: Use of biomarkers in identifying and tracking neurological diseases.

Immunological Disorders: Employment of biomarkers in detecting and treating immune system-related conditions.

Renal Disorders: Application of biomarkers in diagnosing and monitoring kidney diseases.

Other Diseases: Involvement of biomarkers in various other health conditions.

By Type:

Efficacy Biomarkers: Indicators of the effectiveness of a therapeutic intervention.

Safety Biomarkers: Markers that provide information on the safety profile of a treatment.

Validation Biomarkers: Biomarkers used to confirm the accuracy and reliability of diagnostic tests.

By Mechanism:

Genetic Biomarkers: DNA-based markers indicating genetic predispositions.

Epigenetic Biomarkers: Markers reflecting changes in gene expression without altering DNA sequence.

Proteomic Biomarkers: Protein-based markers associated with disease states.

Lipidomic Biomarkers: Lipid-related markers involved in metabolic processes.

Other Mechanisms: Various other biological markers relevant to different conditions.

By End User:

Hospitals and Diagnostic Laboratories: Primary users of biomarkers for patient diagnosis and management.

Research Institutions and Academic Laboratories: Entities engaged in biomarker discovery and validation studies.

Other End Users: Includes pharmaceutical companies and contract research organizations.

By Geography:

North America: Leading market with advanced healthcare infrastructure and significant R&D investments.

Europe: Notable market share driven by robust diagnostic and therapeutic applications.

Asia-Pacific: Fastest-growing region due to increasing healthcare expenditure and rising disease prevalence.

Middle East and Africa: Emerging market with growing focus on healthcare improvements.

South America: Developing market with expanding healthcare services and biomarker adoption.

Get a Customized Report Tailored to Your Requirements. - https://www.mordorintelligence.com/market-analysis/laboratory-supplies

Key Players

The biomarkers market is characterized by the presence of several key players actively contributing to its growth:

Abbott Laboratories Inc.: A global healthcare company offering a wide range of diagnostic solutions, including biomarker-based tests.

Thermo Fisher Scientific: Provides comprehensive laboratory equipment and services, facilitating biomarker research and application.

Biomerieux: Specializes in in vitro diagnostics, offering innovative biomarker assays for various diseases.

Illumina Inc.: Focuses on genetic sequencing technologies, aiding in the discovery of genetic biomarkers.

F. Hoffmann-La Roche Ltd: Engages in pharmaceuticals and diagnostics, with a strong emphasis on biomarker development for personalized medicine.

These companies are investing in research and development, strategic collaborations, and product innovations to enhance their market presence and address the growing demand for biomarker-based diagnostics and therapeutics.

Conclusion

The global biomarkers market is on a robust growth trajectory, propelled by the increasing prevalence of chronic diseases, technological advancements in diagnostics, and collaborative efforts in research and development. The shift towards non-invasive testing and personalized medicine further accentuates the importance of biomarkers in modern healthcare. As key industry players continue to innovate and expand their offerings, the biomarkers market is expected to play a pivotal role in enhancing disease diagnosis, monitoring, and treatment, ultimately improving patient outcomes worldwide.

Industry Related Reports

Cardiac Biomarkers Market: The report provides a comprehensive analysis and insights into the Global Cardiac Biomarkers Market. The market is segmented by Type, including Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and other types. By Application, the market addresses Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, and other related conditions. Based on the Location of Testing, the market is divided into Point-of-Care Testing and Laboratory Testing. Geographically, the market spans key regions such as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, reflecting the global scope and regional dynamics of cardiac biomarker adoption.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/cardiac-biomarkers-market

Cancer Biomarker Market: The report provides a forecast and detailed analysis of the Cancer Biomarker Market. It is segmented by Disease, covering Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and other diseases. By Type, the market includes Protein Biomarkers, Genetic Biomarkers, and other types. The Profiling Technology segment encompasses OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics. Geographically, the market spans North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, highlighting global trends and regional dynamics in the adoption of cancer biomarkers.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/global-cancer-biomarkers-market-industry

Renal Biomarkers Market: The report provides a comprehensive analysis of the Renal Biomarkers Market. It is segmented by Biomarker Type, including Functional Biomarkers, Up-Regulated Proteins, and other biomarker types. By Diagnostic Technique, the market covers Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), and Liquid Chromatography-Mass Spectrometry (LC-MS). The End User segment includes Hospitals, Diagnostic Laboratories, and other healthcare providers. Geographically, the market spans North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, reflecting global and regional trends in the adoption of renal biomarkers for diagnostics and treatment.

To know more visit this link: https://www.mordorintelligence.com/industry-reports/renal-biomarkers-market

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Revolutionizing Healthcare: Explore the Booming Global Biomarkers Market and Its Impact on Modern Medicine here

News-ID: 3784478 • Views:

More Releases from Mordor Intelligence

Fresh Durian Market Booms with Rising Global Demand and Health Trends
Fresh Durian Market Booms with Rising Global Demand and Health Trends
Mordor Intelligence has published a new report on the Fresh Durian Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global fresh durian market is projected to grow from USD 10.78 billion in 2025 to USD 16.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4% during this period. This growth is fueled by increasing health awareness among consumers and
Global Bicycle Market Surges with Green Mobility and Smart Tech Innovations
Global Bicycle Market Surges with Green Mobility and Smart Tech Innovations
Mordor Intelligence has published a new report on the Bicycle Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global bicycle market is poised for significant growth, with projections indicating an increase from USD 58.52 billion in 2025 to USD 71.88 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.2% during this period. This surge is primarily attributed to rising
Rapid Growth in the Quick-Service Restaurant Market Driven by Digital Innovation and Global Expansion
Rapid Growth in the Quick-Service Restaurant Market Driven by Digital Innovation …
Mordor Intelligence has published a new report on the Quick-Service Restaurant Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The Quick-Service Restaurant (QSR) industry is experiencing significant growth, propelled by evolving consumer preferences, technological advancements, and the global expansion of prominent brands. As of 2025, the global QSR market is reflecting a compound annual growth rate (CAGR) of 9.21% during the forecast period.
Camping Equipment Market Thrives with Rising Outdoor Adventures and Eco-Friendly Innovations
Camping Equipment Market Thrives with Rising Outdoor Adventures and Eco-Friendly …
Mordor Intelligence has published a new report on the Camping Equipment Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global camping equipment market is experiencing significant growth, propelled by an increasing interest in outdoor recreational activities, rising disposable incomes, and a heightened focus on health and wellness. As of 2025, the market is valued at USD 20.85 billion and is projected to

All 5 Releases


More Releases for Biomarker

Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF (including full
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period. A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological